Spain charges Merck with pharma abuse
Credit: Vonkara1/iStock
Spain’s competition enforcer has accused Merck’s Spanish and EU businesses of anticompetitively hindering the entry of generic hormonal contraceptives.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now